970 results about "Quinoline" patented technology

The invention discloses an endogenous anti-aging composition based on an internal and external synergistic mechanism and a preparation method of the endogenous anti-aging composition. The endogenous anti-aging composition based on the internal and external synergistic mechanism is prepared from the following components in parts by mass: 100 to 200 parts of alpha-ketoglutarate calcium; 100 to 200 parts of an olive leaf extract; 10 to 20 parts of nicotinic acid; 10 to 20 parts of pyrroloquinoline quinone; 20 to 60 parts of pomegranate extract; and 10 to 30 parts of coenzyme Q10. The composition and the preparation method thereof have the beneficial effects that the composition capable of integrally improving the aging state of women from multiple dimensions and the preparation method of the composition are provided.

The present invention provides a fiber structure having excellent antibacterial properties and washing durability, and a method for producing the same. [Solution] A textile structure having polyamide fibers and containing a dye, a quinoline-based compound, and a phenol derivative, wherein the textile structure contains 0.04% by mass or more of the quinoline-based compound relative to the mass of the textile structure, and even after 10 standard washes in accordance with the "SEK Mark Textile Product Washing Method," the textile structure contains 0.04% by mass or more of the quinoline-based compound relative to the mass of the textile structure, and 0.20% by mass or more and 4.00% by mass or less of the phenol derivative relative to the mass of the textile structure.

The invention discloses a high-whiteness EVA chemical foaming sole material and a preparation method thereof, and belongs to the technical field of footwear products. The EVA chemical foaming sole material is formed by chemical foaming of an EVA composite raw material. The EVA composite raw materials mainly comprise 50 to 70 parts of EVA, 20 to 40 parts of an olefin thermoplastic elastomer, 0.4 to 0.7 part of a peroxide cross-linking agent, 2 to 4 parts of an AC foaming agent, 1 to 2 parts of zinc oxide, 0.3 to 0.8 part of 6-hydroxy-1, 2, 3, 4-tetrahydroquinoline, 0.5 to 1 part of nano zinc carbonate and 0.5 to 1 part of pentaerythritol tetrastearate. The whitening effect of the sole material can be realized on the premise of protecting the EVA foaming-crosslinking structure; therefore, the attractiveness of the product is improved, the durability is better, the mechanical properties and other properties of the EVA foamed sole are not influenced, and the high-quality requirements of elasticity, pressure resistance, comfort and the like of sports shoes can be met.

The application relates to the technical field of silver powder preparation, and discloses a method for producing silver powder by using photovoltaic panel battery pieces, which comprises the following steps: S1, after waste photovoltaic battery pieces and acid liquor are initially mixed, a leaching agent is added for secondary mixing, and filtration is carried out to obtain a silver-containing liquid; S2, sodium chloride is added into the silver-containing liquid to obtain a precipitate; and S3, the precipitate is subjected to reduction treatment to obtain silver powder; and the components of the leaching agent include 8-hydroxyquinoline and / or pyridine-2,6-dicarboxylic acid. Through the technical scheme, the problem of low silver powder yield in the production of silver powder by using photovoltaic battery pieces in the related art is solved.

The invention discloses a mercury ion detection fluorescent probe based on quinoline as well as a preparation method and application of the mercury ion detection fluorescent probe. The fluorescent probe and a structural formula of the fluorescent probe are shown as a formula I in the specification. A quinoline derivative, namely 2-methyl-7-hydroxyquinoline, is used as a fluorescent chromophore, a thioester group is used as a recognition group, and the prepared fluorescent probe shows high sensitivity and high selectivity on Hg < 2 + > in a solution. The preparation method of the fluorescent probe is simple in steps, raw materials are easy to obtain, and the obtained product is a white flocculent solid, is easy to store, has a wide application prospect and can be produced and applied on a large scale.

The invention provides a composition for delaying senescence by activating telomerase activity. The composition is prepared from the following raw materials in parts by weight: 12.5 parts of wheat germ concentrated powder, 0.25 to 5 parts of ergothioneine, 0.25 to 5 parts of pyrroloquinoline quinone disodium salt and 0.25 to 5 parts of alpha-ketoglutaric acid. The invention further provides a preparation method and application of the composition for delaying senescence by activating telomerase activity. Through the synergistic effect of the ergothioneine and the pyrroloquinoline quinone disodium salt, the telomerase activity can be activated, the telomerase expression can be improved, the telomere length can be maintained, and the effect of delaying senescence can be achieved, so that the functional metabolism of a human body can be promoted, and the health state of the body can be improved; through the synergistic effect of the wheat germ concentrated powder and alpha-ketoglutaric acid, cell aging can be delayed; through the multi-target synergistic effect of'telomerase activation + mitochondrial repair + autophagy enhancement ', the anti-aging effect is delayed, the metabolic capability is high, the anti-aging effect is good, and safety and high efficiency are achieved; belongs to the technical field of food and health care product processing.

The invention relates to the technical field of separation and purification devices, in particular to a separation and purification device for 8-hydroxyquinoline crystallization. The device comprises a crystallization kettle used for cooling an 8-hydroxyquinoline solution, a stirring assembly is arranged in the crystallization kettle, the stirring assembly is provided with a plurality of cleaning assemblies in the radial direction of the crystallization kettle, each cleaning assembly comprises a scraping part and a pneumatic part, the scraping parts are slidably connected to the side, close to the inner wall of the crystallization kettle, of the stirring assembly, and the pneumatic parts are arranged on the scraping parts. The pneumatic part is used for pushing the scraping part to be close to the inner wall of the crystallization kettle; the increased air pressure in the pressure-bearing cavity pushes the pressure-bearing plate to slide towards one side close to the contraction groove, the telescopic arm is pushed out of the contraction groove through the sliding rod, and due to the fact that large air pressure is accumulated in the pressure-bearing cavity before the telescopic arm stretches out of the contraction groove, the conical part is inserted into the crystal above the liquid level at the moment that the top of the contraction groove is completely out of shielding of the installation groove. The telescopic arm instantly releases large force, and it can be ensured that the conical part is inserted into crystals tightly combined with the inner wall of the crystallization kettle.

The invention discloses a health-care food for delaying ovarian aging, which belongs to the technical field of health-care foods and comprises a composition for improving the levels of anti-mullerian test tube hormone and superoxide dismutase and functional auxiliary materials, the composition for improving the anti-muller test tube hormone and superoxide dismutase level is prepared from the following components in parts by weight: 2 to 5 parts of pyrroloquinoline quinone PQQ, 30 to 80 parts of cranberry powder and 40 to 100 parts of an isoflavone extract, and the content of the pyrroloquinoline quinone PQQ is 2 to 5 parts, the content of the cranberry powder is 30 to 80 parts, and the content of the isoflavone extract is 40 to 100 parts. The pyrroloquinoline quinone PQQ, the cranberry powder and the isoflavone extract in a specific formula have the effect of synergistically improving the levels of anti-muller test tube hormone and superoxide dismutase, and the health food prepared from the pyrroloquinoline quinone PQQ, the cranberry powder and the isoflavone extract can improve sleep, improve urinary tract infection of middle-aged women, delay ovarian aging and the like.

The invention discloses a preparation method of a liver protection medicine composition containing dihydromyricetin, and relates to the technical field of medicine preparation.According to the method, dihydromyricetin, puerarin, pueraria flower extract, corn oligopeptide, pyrroloquinoline quinone disodium salt, curcumin and ganoderan are used as raw materials; dihydromyricetin and puerarin are stirred, homogenized and dried in a mixed solvent to prepare the liver protection medicine composition, wherein the mass ratio of dihydromyricetin to puerarin is 1: (0.5-2). A multi-target liver protection system is constructed through cooperation of multiple components, the problems that a traditional liver protection medicine is poor in component solubility, easy to degrade in activity and weak in synergistic effect are solved, the bioavailability and stability of the product are improved, the process is simple and controllable, the preparation method is suitable for industrial production and can be prepared into oral preparations such as tablets and oral liquid, and the preparation method is suitable for industrial production. The composition is suitable for protection of alcoholic and chemical liver injury.

The invention discloses a method for determining bedaquiline fumarate clean verification target residues, and relates to the technical field of instrument analysis of chemical pharmacy. The method comprises the following steps: preparing a sample wiping solution; determining the content of bedaquiline fumarate in the sample wiping solution by adopting a liquid chromatography; chromatographic conditions are as follows: a chromatographic column is a VP-ODS C18 column; mobile phases: a potassium hexafluorophosphate aqueous solution and acetonitrile, wherein the concentration of the potassium hexafluorophosphate aqueous solution is 0.01-0.03 mol / L; the elution mode is isocratic elution; the flow rate is 1 ml / min to 2 ml / min; the column temperature is 28-32 DEG C; the method has good specificity and sensitivity for determination of bedaquiline fumarate cleaning verification target residues, is simple and convenient to operate, rapid in determination, simple and easy to implement, and overcomes the defects that TOC, chemical titration methods, conductivity methods, pH methods and the like which are commonly used at present do not have specificity.

The present invention relates to pharmaceutical compositions containing N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3, 3-trifluoro-2,2-dimethyl-propoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide, a solid dispersion of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-7V-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-en indol-5-yl)cyclopropanecarboxamide, and a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-quinoline-3-carboxamide, including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical compositions.

Provided in the present invention are a compound as represented by formula (I), or a pharmaceutically acceptable salt, a tautomer, a geometrical isomer, an optical isomer, a solvate or an isotopic derivative thereof, and the use thereof. The compound of the present invention has a significant inhibitory activity on PRMT5, has a significant inhibitory effect on tumor cells and in vivo tumor models, also has a good administration performance, and has clinical application potential for preventing and / or treating diseases which are at least partially mediated by PRMT5.

The invention discloses a dual-band dianthracene photocatalyst as well as a preparation method and application thereof, and belongs to the field of heterocyclic compounds. The novel 2, 9 '-dianthracene photocatalyst is designed and synthesized, the compatibility at the two wavebands of 365 nm and 405 nm is good, the tetrahydroisoquinoline phosphoramidite can be induced by light, and a new thought is provided for preparing an alpha-phosphoramidate compound; the reaction conditions are mild, the reaction time is short, the photocatalyst can be recycled, the circulation loss is low, the circulation efficiency is high, the production efficiency is greatly improved, and the production period and cost are reduced; the product is free of transition metal residues and high in yield.

The present application relates to a kind of macromolecular heavy metal complexing agent containing 8-hydroxyquinoline and amido phosphate structure and its preparation method, the present application also relates to a kind of heavy metal antidote, and the use of the macromolecular heavy metal complexing agent of the present application in preparing drug for treating heavy metal poisoning.The macromolecular complexing agent of the present application has excellent binding capacity with cadmium, lead, mercury and other heavy metal ions, and is high in safety, has excellent and long-acting heavy metal protection effect.The preparation method of the present application can mass, simply and efficiently prepare the macromolecular complexing agent of the present application, and preparation process is simple, high in yield, raw material is cheap and easy to obtain, reaction condition is mild.

The invention relates to the field of PQQ production, in particular to an engineering bacterium for producing pyrroloquinoline quinone and a preparation method of the engineering bacterium. According to the invention, different broad-host shuttle vectors are used, PQQ is expressed in denitrifying hyphomicrobe to synthesize related gene clusters, denitrifying hyphomicrobe engineering bacteria with high yield of PQQ are successfully constructed, and the engineering bacteria have the characteristics of rapid growth, high fermentation yield and the like, and lay a foundation for realizing green production of PQQ.

The application discloses a quinoline small molecule blended modified polymer dielectric material and a preparation method and application thereof, and belongs to the technical field of capacitor films. The preparation raw materials comprise quinoline derivatives, polymethyl methacrylate, styrene-methyl methacrylate copolymer, polyetherimide, polypropylene and N-methyl pyrrolidone solution, and the preparation steps comprise blending and film preparation. The blending solution or eutectic mixture is prepared through blending, and the polymer dielectric film is prepared through a flow casting method or bidirectional stretching. The prepared quinoline small molecule blended modified polymer dielectric film has excellent electrical properties, can reduce the leakage current of the polymer material, has high DC breakdown field strength, high energy storage density and low energy loss, and is easy to realize large-scale production.

The invention relates to an anti-aging capsule compounded by PQQ and mitochondrial nutrients, and discloses an anti-aging capsule which is prepared by synergistically compounding a plurality of mitochondrial nutrients according to a scientific proportion and supplementing high-purity raw materials and slow-release dosage forms to realize energy metabolism activation and anti-oxidation synergistic intervention. Therefore, the anti-aging capsule systematically delays aging through multi-target regulation and control of mitochondrial functions. The capsule is characterized by comprising the following components in parts by weight: 1-20 mg of pyrroloquinoline quinone disodium salt (PQQ), 20-100 mg of coenzyme Q10, 50-200 mg of L-carnitine tartrate, 10-100 mg of alpha-lipoic acid, 50-300 mg of nicotinamide mononucleotide (NMN) or nicotinamide nucleoside (NR), and 10-50 [mu] g of selenoprotein or organic selenium yeast, and a capsule carrier comprises 100 mg of gelatin or a plant-derived capsule shell, 180 mg of microcrystalline cellulose, 5 mg of magnesium stearate and 5 mg of silicon dioxide.

The invention discloses a cephalotaxus hainanensis Ch2OGD1 gene and application thereof, and belongs to the technical field of gene engineering. The Ch2OGD1 gene is used for coding a 2-oxoglutaric acid dependent dioxygenase (2OGD) type Pictet-Spengler enzyme, and the Pictet-Spengler enzyme is used for coding a Pictet-Spengler enzyme. Through a tobacco transient expression system and in-vitro enzyme activity determination, the Ch2OGD1 is proved to be capable of specifically catalyzing the condensation of dopamine and 4-hydroxyphenylpropanal to generate 1-phenethyl isoquinoline. The invention provides a directional preparation method of 1-phenethyl isoquinoline based on the Ch2OGD1 gene, provides a key enzyme element for biosynthesis of a cephalotaxine alkaloid precursor compound, and provides a technical basis for expanding the application of the gene in plant genetic engineering. And a potential technical path is provided for relieving the problem of resource shortage of cephalotaxine alkaloids.

The invention discloses a fluorescent probe for detecting spermine and spermidine in a water sample and urine as well as a preparation method and application of the fluorescent probe, and relates to the technical field of supramolecular fluorescent probes, and the fluorescent probe is formed by reacting 14-membered cucurbit urils (tQ [14]) and a compound (E)-1-(4-boron benzyl)-4-(4-hydroxyl styryl) quinoline-1-ammonium bromide according to a molar ratio of 1: 1. The novel fluorescent probe provided by the invention can specifically detect spermine and spermidine in a water sample and urine, and the preparation method of the fluorescent probe is simple and easy to implement; the method for detecting spermine and spermidine in a water sample and urine by using the fluorescent probe has the advantages of high sensitivity, high selectivity, low cost, simple sample treatment, convenient operation, rapid determination and the like.

The invention discloses a novel fused heterocyclic compound and application thereof, and an organic electroluminescent device comprising the compound, relates to the technical field of organic electroluminescence, and provides a high-efficiency and long-life green light-emitting material based on a boron-nitrogen skeleton and application of the high-efficiency and long-life green light-emitting material. The compound is designed on the basis of a single-spiro structure material FBN (CAS: 3018116-98-5), a benzene ring on a carbazole unit connected with a spiro ring is replaced with a naphthalene, quinoline or fused ring structure, and substituent groups can be introduced into other fragments for modification. According to the design, the luminous nuclear rigidity is improved, non-radiative vibration is inhibited, the spectrum is narrowed, and the color purity and efficiency are improved; the single-spiro structure is beneficial to control of molecular weight and enhancement of evaporation stability; the HOMO / LUMO delocalization range is expanded by molecular conjugation enhancement, the stability is improved, and the service life of the device is prolonged.

The invention discloses a method for cyclizing imine bonds of Schiff base COFs, and belongs to the field of materials. The method comprises the following steps: mixing Schiff base COFs, pyruvic acid and a solvent, and reacting by taking air as a dehydrogenation reagent to obtain quinoline COFs. The method disclosed by the invention is simple and efficient, the quinoline COFs with different topological structures can be prepared by utilizing the method, and the obtained quinoline COFs keep the crystallinity and porosity of a Schiff base COFs precursor.

The present invention relates to a Ru-Ni bimetallic catalyst for the selective hydrogenation of a quinoline organic hydrogen storage carrier, and a preparation method therefor and the use thereof. In the catalyst, carbon nitride is used as a carrier, and metal nanoparticles Ru and Ni serve as active components and are jointly loaded on the carbon nitride carrier; and the carbon nitride is prepared by mixing carbon tetrachloride, ethidene diamine and nano-silica, reacting same to obtain a carbon nitride polymer, then calcining same at 750-850ºC, performing a desilicification treatment, and then filtering and drying same. The catalyst provided in the present application has good catalytic hydrogenation performance in the selective hydrogenation of the quinoline organic hydrogen storage carrier and can achieve the omission of a solvent in a reaction system; the reaction is simple, green and environmentally friendly, and the gravimetric hydrogen storage density of the system can be maximally ensured when a quinoline compound is used as an organic hydrogen carrier; moreover, the catalyst also has a good cycling stability.

The invention relates to a preparation method of a drug intermediate 2-amino-3-hydroxypyridine, and relates to the technical field of medicines. Adding water, acid, sodium chloride, furfural and a sulfamate solution into the reaction kettle, and stirring for reaction; after the reaction is finished, carrying out centrifugal separation to obtain 2-imino-3-hydroxypyridine sulfonic acid; the preparation method comprises the following steps: adding water and 2-imino-3-hydroxypyridine sulfonic acid into a reaction kettle, heating and stirring to react, adding modified amino phosphonic acid type chelating resin, stirring and adsorbing, adjusting the pH value to 6-8 by using an inorganic alkali solution, centrifuging and drying to obtain 2-amino-3-hydroxypyridine; the modified amino phosphonic acid type chelating resin is prepared from amino phosphonic acid type chelating resin, 10 # white oil, aluminum chloride and 5-quinoline sulfonyl chloride. According to the method, the 2-amino-3-hydroxypyridine with higher yield and purity can be obtained, and the method has a good industrial application prospect.

The application discloses a kind of compositions, reagents and its detection method for high-throughput gene sequencing, belong to gene sequencing technical field, the composition includes Tris-HCl buffer 80-120 parts, potassium chloride 40-60 parts, ammonium sulfate 10-20 parts, magnesium chloride 15-25 parts, dNTPs mixed solution 30-50 parts, heat-stable DNA polymerase mutant 8-15 parts, PCR promoter complex 5-12 parts, modified iridium quinoline ketone complex 1-5 parts, glycerol 150-250 parts, Tween-20 1-3 parts, EDTA disodium salt 0.5-2 parts and nuclease-free ultrapure water, by introducing the modified iridium quinoline ketone complex of innovation, effectively solve the technical problems of low amplification efficiency, poor multiplex PCR reaction uniformity and high non-specific amplification background for high GC content, complex secondary structure genomic template, significantly improve the specificity of amplification, uniformity and the quality and reliability of final sequencing data.

The invention belongs to the technical field of battery materials, and particularly relates to a method for determining iron phosphide in a phosphate positive electrode material, the positive electrode material and application. Comprising the following steps: preparing standard solutions of a series of phosphate positive electrode materials with different iron phosphide contents; respectively collecting and purifying magnetic substances in the standard solutions, and adding a quimocilidone reagent to determine the corresponding quinoline phosphomolybdate precipitate; drawing a standard curve according to the mass of the iron phosphide and the mass of the quinoline phosphomolybdate precipitate in the standard solutions with different iron phosphide contents; preparing a to-be-detected solution, collecting and purifying magnetic substances in the to-be-detected solution, adding a quinmolybdenum citronone reagent to determine the mass of the quinoline phosphomolybdate precipitate, and calculating the content of iron phosphide in the to-be-detected phosphate positive electrode material. By means of the method, the content of trace iron phosphide in the phosphate positive electrode material can be efficiently, accurately and quantitatively analyzed, the content of iron phosphide in the phosphate positive electrode material can be quantitatively regulated and reduced, and the electrochemical performance of the phosphate positive electrode material is improved.

The application discloses a preparation method of enciferstat bulk drug and belongs to the field of drug synthesis. 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one (SM) is used as a raw material, and the raw material is reacted with cyclohexylamine under alkaline conditions, and the reaction is washed with water, dried, and concentrated to obtain an intermediate I; the intermediate I is reacted with urea under pressurized heating conditions to prepare an enciferstat drug molecule, the two-step yield is more than 67%, and the purity is more than 99%, the method has a simple operation process, the product is easy to purify, the yield is high, the product purity is high, and a new method for preparing enciferstat bulk drug is provided.

A polishing liquid for CMP, the polishing liquid containing abrasive grains, a nitrogen-containing compound, and water, in which the abrasive grains include cerium-based particles, and the nitrogen-containing compound includes a compound A1 having a fused ring (a fused ring having an aromatic five-membered ring with one nitrogen atom), a compound A2 having a quinoline ring and one hydroxy group bonded to the quinoline ring, a compound A3 having an aromatic ring and a hydroxy group bonded to a nitrogen atom, or a compound A4 having a nitrogen-containing aromatic ring to which at least one selected from the group consisting of a hydroxy group and an amino group is bonded.

Disclosed is a quinoline compound and a use thereof. A quinoline derivative of the present invention is a compound having phosphodiesterase 3A (PDE3A) inhibitory activity, has important potential therapeutic value, and is used in the treatment of cerebrovascular diseases or in dementia drugs.

The application discloses a PO4 3‑ and a preparation method of a flame-retardant epoxy acrylate coating layer of 8-OQ intercalated zinc-aluminum hydrotalcite, and the coating layer. Phosphate ions are intercalated between layers by using the ion-exchangeability between layers, and other intercalation agents are used to increase the intercalation rate of phosphate ions before the phosphate ions are embedded into the layers. 8-hydroxyquinoline as an intercalation agent can effectively expand the interlayer spacing of hydrotalcite, and provide more space for anion exchange. The Zn / Al-PO4 3‑ -LDHs intercalated with 8-hydroxyquinoline has the optimal flame-retardant and mechanical properties of the coating layer of the EA compound system. The hydrotalcite can make the carbon layer more uniform, more dense and more solid, and increase the carbon content of the coating layer, so as to improve the flame retardancy and thermal stability of the composite coating, and provide a new method for the research on the hydrotalcite modified EA fireproof coating.

This invention provides a method for preparing a foamed copper-based composite organic compound layer catalytic material, comprising the following steps: forming 8-hydroxyquinoline molybdenum (Mo(C)) on the surface of a foamed copper matrix. 9 H 6 NO) 4 Organic compound layer; 8-hydroxyquinoline molybdenum (Mo(C)) 9 H 6 NO) 4 The organic compound layer is converted into phthalimide 8-hydroxyquinoline molybdenum (C). 8 H 4 NO 2 ) 2 (C 9 H 6 NO) 2 ; Phthalimide 8-hydroxyquinoline molybdenum Mo(C) 8 H 4 NO 2 ) 2 (C 9 H 6 NO) 2 Conversion to copper phthalimide / 8-hydroxyquinoline molybdenum Cu(C) 8 H 4 NO 2 ) 2 / Mo(C 9 H 6 NO) 2 The foamed copper-based composite organic compound layer catalytic material is finally obtained. The catalytic material prepared by the method of this invention can effectively improve the Faradaic efficiency, ammonia selectivity, production rate, and nitrate removal rate of the electrochemical reduction of nitrate to ammonia technology.